Who we are
The BBV & STI Research, Intervention and Strategic Evaluation Program (BRISE) at UNSW Australia undertakes policy-relevant research to support NSW Health in reducing blood-borne viruses (BBV) and sexually transmissible infections (STI) in NSW, as well as improving the health outcomes of people living with these infections.
BRISE’s mission is to deliver a world-class BBV and STI research program that provides evidence and strategic advice that focuses on the prevention and diagnosis of infections, and treatment and care of people living with infection.
BRISE has been funded by NSW Health for five years (1 July 2014 – 30 June 2019) and brings together leading experts in the field of BBV and STI from the UNSW faculties of Medicine and Arts & Social Sciences.
BRISE supports the following BBV and STI related strategic goals of NSW Health:
- Work towards the virtual elimination of HIV transmission in NSW by 2020
- Reduce hepatitis infections in NSW
- Improve the health outcomes of people living with hepatitis in NSW
- Reduce the transmission of STIs
- Reduce morbidity associated with STIs
Facilitating BBV and STI research
Promote use of research
Building research capacity